{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:27:07Z","timestamp":1793924827181,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.colsurfb.2026.116182","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:21:29Z","timestamp":1789662089000},"page":"116182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["sFgl2\u2011enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity"],"prefix":"10.1016","volume":"269","author":[{"given":"Guoshan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danzhou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-0985","authenticated-orcid":false,"given":"Feng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12964-023-01386-9","article-title":"Macrophage polarization in inflammatory bowel disease","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell. Commun. Signal."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.116182_bib2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/ecco-jcc\/jjac051","article-title":"Pain Characteristics in patients with inflammatory bowel disease: a monocentric cross-sectional study","volume":"16","author":"Hardy","year":"2022","journal-title":"J. Crohns Colitis"},{"issue":"8067","key":"10.1016\/j.colsurfb.2026.116182_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-025-08940-0","article-title":"Global evolution of inflammatory bowel disease across epidemiologic stages","volume":"642","author":"Hracs","year":"2025","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.colsurfb.2026.116182_bib4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.116182_bib5","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1053\/j.gastro.2021.09.076","article-title":"Evolving short- and long-term goals of management of inflammatory bowel diseases: getting it right, making it last","volume":"162","author":"Le Berre","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.colsurfb.2026.116182_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691480","article-title":"Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice","volume":"12","author":"Bruscoli","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.116182_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1517\/14712598.2010.519333","article-title":"Mesenchymal stem cells: biological properties and clinical applications","volume":"10","author":"Garc\u00eda-G\u00f3mez","year":"2010","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.116182_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s12015-011-9228-8","article-title":"Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation","volume":"7","author":"Pontikoglou","year":"2011","journal-title":"Stem Cell. Rev. Rep."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.116182_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123433","article-title":"Adipose tissue-derived mesenchymal stem cells","volume":"10","author":"Bunnell","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.116182_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10735-021-10048-4","article-title":"Overview of signal transduction between LL37 and bone marrow-derived MSCs","volume":"53","author":"Zhu","year":"2022","journal-title":"J. Mol. Histol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13287-022-02990-1","article-title":"Human umbilical cord blood-derived MSCs trans-differentiate into endometrial cells and regulate Th17\/Treg balance through NF-\u03baB signaling in rabbit intrauterine adhesions endometrium","volume":"13","author":"Hua","year":"2022","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.colsurfb.2026.116182_bib12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jare.2024.05.004","article-title":"Mesenchymal stem cell secretome for regenerative medicine: where do we stand?","volume":"70","author":"Trigo","year":"2025","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13287-021-02697-9","article-title":"The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review","volume":"13","author":"Bian","year":"2022","journal-title":"Stem Cell. Res. Ther."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.116182_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/stem.2575","article-title":"Concise review: MSC-derived exosomes for cell-free therapy","volume":"35","author":"Phinney","year":"2017","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-022-02811-5","article-title":"The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer","volume":"13","author":"Guo","year":"2022","journal-title":"Stem Cell. Res. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib16","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41598-024-51217-1","article-title":"FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models","volume":"14","author":"Galpin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.colsurfb.2026.116182_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115678","article-title":"MSC-derived exosomes carrying sFgl2 alleviate acute rejection of mouse heart transplantation by regulating macrophage polarization","volume":"167","author":"Chen","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.116182_bib18","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.7150\/thno.50182","article-title":"Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5(n-3 DPA) production","volume":"11","author":"Lei","year":"2021","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.colsurfb.2026.116182_bib19","doi-asserted-by":"crossref","first-page":"eaay9269","DOI":"10.1126\/sciadv.aay9269","article-title":"Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2","volume":"6","author":"Fu","year":"2020","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.colsurfb.2026.116182_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41419-020-02788-0","article-title":"IFN-\u03b3 promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b","volume":"11","author":"Yang","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.colsurfb.2026.116182_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627605","article-title":"Extracellular vesicles secreted by mesenchymal stromal cells exert opposite effects to their cells of origin in murine sodium dextran sulfate-induced colitis","volume":"12","author":"Tolomeo","year":"2021","journal-title":"Front. Immunol."},{"issue":"28","key":"10.1016\/j.colsurfb.2026.116182_bib22","doi-asserted-by":"crossref","first-page":"38483","DOI":"10.1021\/acsami.6c07496","article-title":"Oral delivery of mesenchymal stem cell-derived extracellular vesicles to treat intestinal inflammation","volume":"18","author":"Belaid","year":"2026","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12951-021-00894-5","article-title":"Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis","volume":"19","author":"Hu","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.116182_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2405698","article-title":"B7-H1 expression is required for human endometrial regenerative cells in the prevention of transplant vasculopathy in mice","volume":"2018","author":"Ye","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.colsurfb.2026.116182_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-9167-9_4","article-title":"Bone marrow-derived dendritic cells","volume":"1960","author":"Roney","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-021-04394-0","article-title":"GPR120 induces regulatory dendritic cells by inhibiting HK2-dependent glycolysis to alleviate fulminant hepatic failure","volume":"13","author":"Yu","year":"2021","journal-title":"Cell. Death Dis."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.116182_bib27","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1172\/JCI39134","article-title":"Dendritic cells in intestinal homeostasis and disease","volume":"119","author":"Rescigno","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.colsurfb.2026.116182_bib28","article-title":"Dendritic cells: the yin and yang in disease progression","volume":"14","author":"Jim\u00e9nez-Cortegana","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.colsurfb.2026.116182_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112825","article-title":"IGF2 contributes to the immunomodulatory effects of exosomes from endometrial regenerative cells on experimental colitis","volume":"140","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"8071","key":"10.1016\/j.colsurfb.2026.116182_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-025-09000-3","article-title":"STAT5 and STAT3 balance shapes dendritic cell function and tumour immunity","volume":"643","author":"Zhou","year":"2025","journal-title":"Nature"},{"issue":"Pt B","key":"10.1016\/j.colsurfb.2026.116182_bib31","article-title":"Combination of matrine and tacrolimus alleviates acute rejection in murine heart transplantation by inhibiting DCs maturation through ROS\/ERK\/NF-\u03baB pathway","volume":"101","author":"Zheng","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib32","doi-asserted-by":"crossref","DOI":"10.18103\/mra.v11i1.3135","article-title":"Inflammatory bowel disease: clinical diagnosis and pharmaceutical management","volume":"11","author":"M'Koma","year":"2023","journal-title":"Med. Res. Arch."},{"issue":"23","key":"10.1016\/j.colsurfb.2026.116182_bib33","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.116182_bib34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.colsurfb.2026.116182_bib35","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1905725","article-title":"Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis","volume":"381","author":"Sands","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.colsurfb.2026.116182_bib36","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1606910","article-title":"Tofacitinib as induction and maintenance therapy for ulcerative colitis","volume":"376","author":"Sandborn","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10341","key":"10.1016\/j.colsurfb.2026.116182_bib37","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(22)00581-5","article-title":"Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials","volume":"399","author":"Danese","year":"2022","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.colsurfb.2026.116182_bib38","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","article-title":"Ozanimod as induction and maintenance therapy for ulcerative colitis","volume":"385","author":"Sandborn","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10383","key":"10.1016\/j.colsurfb.2026.116182_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(23)00061-2","article-title":"Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies","volume":"401","author":"Sandborn","year":"2023","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.colsurfb.2026.116182_bib40","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","article-title":"Mirikizumab as induction and maintenance therapy for ulcerative colitis","volume":"388","author":"D'Haens","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"10472","key":"10.1016\/j.colsurfb.2026.116182_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0140-6736(24)01927-5","article-title":"Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies","volume":"405","author":"Rubin","year":"2025","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.colsurfb.2026.116182_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf074","article-title":"Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b study","volume":"19","author":"Vermeire","year":"2025","journal-title":"J. Crohns Colitis"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.116182_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa2314076","article-title":"Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis","volume":"391","author":"Sands","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.colsurfb.2026.116182_bib44","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.3748\/wjg.v30.i22.2902","article-title":"Approach to loss of response to advanced therapies in inflammatory bowel disease","volume":"30","author":"Vootukuru","year":"2024","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.116182_bib45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/apt.16712","article-title":"Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatment","volume":"55","author":"Sandborn","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12951-022-01421-w","article-title":"Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.116182_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.749192","article-title":"Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front. Immunol."},{"issue":"24","key":"10.1016\/j.colsurfb.2026.116182_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131273","article-title":"Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13287-023-03263-1","article-title":"Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3 + Treg cells and gut microbiota","volume":"14","author":"Yan","year":"2023","journal-title":"Stem Cell. Res. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41368-021-00150-4","article-title":"Exosomes derived from 3D-cultured MSCs improve therapeutic effects in periodontitis and experimental colitis and restore the Th17 cell\/Treg balance in inflamed periodontium","volume":"13","author":"Zhang","year":"2021","journal-title":"Int. J. Oral. Sci."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.116182_bib51","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41590-024-01882-1","article-title":"Reciprocal regulation of T follicular helper cells and dendritic cells drives colitis development","volume":"25","author":"Bai","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.colsurfb.2026.116182_bib52","article-title":"Gpr174 knockout alleviates DSS-induced colitis via regulating the immune function of dendritic cells","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib53","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2412669","article-title":"Clostridium sporogenes-derived metabolites protect mice against colonic inflammation","volume":"16","author":"Krause","year":"2024","journal-title":"Gut Microbes"},{"issue":"14","key":"10.1016\/j.colsurfb.2026.116182_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147618","article-title":"Innate lymphoid cells in intestinal homeostasis and inflammatory bowel disease","volume":"22","author":"Saez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.116182_bib55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s42003-021-02018-z","article-title":"Regulatory T cells induce polarization of pro-repair macrophages by secreting sFGL2 into the endometriotic milieu","volume":"4","author":"Hou","year":"2021","journal-title":"Commun. Biol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526007708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526007708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:53:56Z","timestamp":1793922836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526007708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":55,"alternative-id":["S0927776526007708"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116182","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"sFgl2\u2011enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.116182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116182"}}